Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7223-7233

  Ji, Jong Dae ^a,b   Park Min, Kyung Hyun ^a   Shen, Zenxin ^c   Fajardo, Roberto J ^c   Goldring, Steven R ^a,c   McHugh, Kevin P ^c   Ivashkiv, Lionel B ^a,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Korea University College of Medicine   (South Korea)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; MESSENGER RNA; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TNFRSF11A PROTEIN, HUMAN; TREM2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION; INFLAMMATION; LIGAND BINDING; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; STEM CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, IMMUNOLOGIC; STEM CELLS; TOLL-LIKE RECEPTORS;

EID: 73349101077     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900072     Document Type: Article

References (41)

1. Lorenzo, J., M. Horowitz, and Y. Choi. 2008. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29: 403-440. (Pubitemid 351831507)
2. Bartold, P. M., R. I. Marshall, and D. R. Haynes. 2005. Periodontitis and rheumatoid arthritis: a review. J. Periodontol. 76: 2066-2074.
3. McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7: 429-442.
4. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson, and T. Suda. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J. Exp. Med. 190: 1741-1754. (Pubitemid 30013841)
5. Takayanagi, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304. (Pubitemid 46480961)
6. Teitelbaum, S. L. 2006. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8: 201.
7. Evans, K. E., and S. W. Fox. 2007. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 8: 4.
8. Lari, R., A. J. Fleetwood, P. D. Kitchener, A. D. Cook, D. Pavasovic, P. J. Hertzog, and J. A. Hamilton. 2007. Macrophage lineage phenotypes and osteoclastogenesis: complexity in the control by GM-CSF and TGF-β. Bone 40: 323-336. (Pubitemid 46054560)
9. Takayanagi, H., S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, E. F. Wagner, and T. Taniguchi. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416: 744-749. (Pubitemid 34429151)
10. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, K. Nakamura, and T. Taniguchi. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
11. Wei, S., M. W. Wang, S. L. Teitelbaum, and F. P. Ross. 2002. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and mitogen-activated protein kinase signaling. J. Biol. Chem. 277: 6622-6630. (Pubitemid 34968463)
12. Kawai, T., and S. Akira. 2007. TLR signaling. Semin. Immunol. 19: 24-32.
13. Itoh, K., N. Udagawa, K. Kobayashi, K. Suda, X. Li, M. Takami, N. Okahashi, T. Nishihara, and N. Takahashi. 2003. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170: 3688-3695. (Pubitemid 36359239)
14. Kikuchi, T., T. Matsuguchi, N. Tsuboi, A. Mitani, S. Tanaka, M. Matsuoka, G. Yamamoto, T. Hishikawa, T. Noguchi, and Y. Yoshikai. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166: 3574-3579. (Pubitemid 33117363)
15. Mochizuki, A., M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al. 2006. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand. J. Immunol. 177: 4360-4368.
16. Sato, N., N. Takahashi, K. Suda, M. Nakamura, M. Yamaki, T. Ninomiya, Y. Kobayashi, H. Takada, K. Shibata, M. Yamamoto, et al. 2004. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1α. J. Exp. Med. 200: 601-611.
17. Han, X., T. Kawai, and M. A. Taubman. 2007. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol. 2000 45: 76-94.
18. Walsh, N. C., T. N. Crotti, S. R. Goldring, and E. M. Gravallese. 2005. Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev. 208: 228-251.
19. Chiang, C. Y., G. Kyritsis, D. T. Graves, and S. Amar. 1999. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect. Immun. 67: 4231-4236.
20. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
21. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
22. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169: 1516-1523. (Pubitemid 34809198)
23. Zou, W., and Z. Bar-Shavit. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. J. Bone Miner. Res. 17: 1211-1218. (Pubitemid 34680497)
24. Zou, W., H. Schwartz, S. Endres, G. Hartmann, and Z. Bar-Shavit. 2002. CpG oligonucleotides: novel regulators of osteoclast differentiation. FASEB J. 16: 274-282. (Pubitemid 34195289)
25. Ha, H., J. H. Lee, H. N. Kim, H. B. Kwak, H. M. Kim, S. E. Lee, J. H. Rhee, H. H. Kim, and Z. H. Lee. 2008. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-β. J. Immunol. 180: 1382-1389.
26. Takayanagi, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83: 170-179. (Pubitemid 40487405)
27. + monocytes isolated from peripheral blood. J. Bone Miner. Metab. 25: 36-45.
28. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3: 392-398. (Pubitemid 34308628)
29. Cella, M., C. Buonsanti, C. Strader, T. Kondo, A. Salmaggi, and M. Colonna. 2003. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198: 645-651. (Pubitemid 37040398)
30. Colonna, M., I. Turnbull, and J. Klesney-Tait. 2007. The enigmatic function of TREM-2 in osteoclastogenesis. Adv. Exp. Med. Biol. 602: 97-105.
31. Paloneva, J., M. Kestila, J. Wu, A. Salminen, T. Bohling, V. Ruotsalainen, P. Hakola, A. B. Bakker, J. H. Phillips, P. Pekkarinen, et al. 2000. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25: 357-361.
32. Paloneva, J., T. Manninen, G. Christman, K. Hovanes, J. Mandelin, R. Adolfsson, M. Bianchin, T. Bird, R. Miranda, A. Salmaggi, et al. 2002. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71: 656-662.
33. Goldring, S. R., M. Roelke, and J. Glowacki. 1988. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin. J. Bone Miner. Res. 3: 117-120.
34. Murray, P. J. 2005. The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102: 8686-8691.
35. Baccarini, M., P. Dello Sbarba, D. Buscher, A. Bartocci, and E. R. Stanley. 1992. IFN-γ/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor. J. Immunol. 149: 2656-2661.
36. Rettenmier, C. W., M. F. Roussel, R. A. Ashmun, P. Ralph, K. Price, and C. J. Sherr. 1987. Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol. Cell Biol. 7: 2378-2387.
37. Rovida, E., A. Paccagnini, M. Del Rosso, J. Peschon, and P. Dello Sbarba. 2001. TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J. Immunol. 166: 1583-1589. (Pubitemid 32114638)
38. Blobel, C. P. 2005. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6: 32-43.
39. Hu, X., J. Chen, L. Wang, and L. B. Ivashkiv. 2007. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukocyte Biol. 82: 237-243. (Pubitemid 47230632)
40. Liu, J., S. Wang, P. Zhang, N. Said-Al-Naief, S. M. Michalek, and X. Feng. 2009. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J. Biol. Chem. 284: 12512-12523.
41. Park-Min, K. H., J. D. Ji, T. Antoniv, A. C. Reid, R. B. Silver, M. B. Humphrey, M. Nakamura, and L. B. Ivashkiv. 2009. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-κB signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J. Immunol. 183: 2444-2455.